Gln-Atovaquone 750 mg

Atovaquone 750 mg suspension is an oral medication used to treat certain infections. This broad-spectrum antiparasitic is commonly prescribed for conditions like malaria and pneumonia.

Atovaquone 750 mg suspension is primarily used to treat parasitic infections, including malaria and pneumonia caused by Pneumocystis jirovecii. It is often prescribed for individuals who cannot tolerate or do not respond to other treatments. The medication works by interfering with the parasite's ability to reproduce, helping to clear the infection.

Common effects of Atovaquone 750 mg suspension may include nausea, vomiting, diarrhea, and stomach pain. Some users might experience headache, dizziness, or rash. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Atovaquone 750 mg suspension should be used with caution in individuals with liver or kidney problems. It is important to follow the prescribed dosage and complete the full course of treatment. Avoid taking this medication with high-fat meals, as it can reduce its effectiveness. Always store the suspension properly and keep it out of reach of children.

Atovaquone 750 mg suspension may interact with certain medications, including antacids, metoclopramide, and drugs that induce liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited, as it may exacerbate side effects.